Back to BCAX
CoreCap Advisors, LLC BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
5
Latest value
$596
Q3 2026
Peak value
$950
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $505 |
| Q4 2025 | $539 |
| Q1 2026 | $636 |
| Q2 2026 | $950 |
| Q3 2026 | $596 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $596 | 32 | — | — |
| Q2 2026 | $950 | 32 | — | — |
| Q1 2026 | $636 | 32 | — | — |
| Q4 2025 | $539 | 32 | — | — |
| Q3 2025 | $505 | 32 | — | — |
Other funds holding BCAX
$93.9M
$63.1M
$60.8M
$60.8M
$54.4M
$53.4M
$50.1M
Other CoreCap Advisors, LLC positions
VGES
$183.4MVANGUARD MORNINGSTAR TOTAL STOCK MARKET ETF
STT-PG
$182.2MSTATE STREET SPDR PORTFOLIO S&P 500 GROWTH ETF
VGES
$178.1MVANGUARD TOTAL STOCK MARKET ETF
STT-PG
$177.2MSTATE STREET SPDR PORTFOLIO S&P 500 GROWTH ETF
STT-PG
$159.1MSPDR PORTFOLIO S&P 500 GROWTH ETF
VGES
$156.6MVANGUARD TOTAL STOCK MARKET ETF
STT-PG
$156.5MSTATE STREET SPDR PORTFOLIO S&P 500 GROWTH ETF
VGES
$149MVANGUARD TOTAL STOCK MARKET ETF